Brooks, Maria Mori
- University of Pittsburgh · Public Health (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #12,783
- Sustained Excellence
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2013 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Public Health
NIH Funding · FY2023
Linked Award Amount
$828.6K
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#12,783
By linked amount among FY2023 PIs
Earliest Year Loaded
2013
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Brooks, Maria Mori as a PI. Multi-PI records show the full award amount for context.
- 5U24HL143217-05U24Contact PI2/2 Sickle Cell Disease and CardiovAscular Risk - Red cell Exchange Trial (SCD-CARRE Trial)University of Pittsburgh · Public Health (NIH department code)$715Kaward amount
- 3U19AG063720-03S2U19Contact PIThe Study of Women's Health Across the Nation (SWAN): The Impact of Midlife and the Menopause Transition on Health and Functioning in Early Old AgeUniversity of Pittsburgh · Public Health (NIH department code)$113.6Kaward amount
Award organization
Organizations that administered FY2023 awards listing Brooks, Maria Mori as a PI.
FY2023 award administered by University of Pittsburgh (PA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2013First NIH AwardUniversity of Pittsburgh
- 2013$500K Cumulative Funding
- 2013$1M Cumulative Funding
- 2013Entered Top 50% NationallyRanked #2962
- 2013Entered Top 25% NationallyRanked #2962
- 2014$2M Cumulative Funding
- 2014Entered Top 10% NationallyRanked #1637
- 2015$5M Cumulative Funding
- 2016$10M Cumulative Funding
- 2020$25M Cumulative Funding
- 2020Entered Top 5% NationallyRanked #35
- 2020Entered Top 1% NationallyRanked #35
- 2022$50M Cumulative Funding